165 related articles for article (PubMed ID: 7037463)
1. Induction of luteolysis by luteinizing hormone-releasing factor (LRF) agonist: sensitivity, reproducibility, and reversibility.
Sheehan KL; Casper RF; Yen SS
Fertil Steril; 1982 Feb; 37(2):209-12. PubMed ID: 7037463
[TBL] [Abstract][Full Text] [Related]
2. Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women.
Roseff SJ; Kettel LM; Rivier J; Burger HG; Baulieu E; Yen SS
Fertil Steril; 1990 Nov; 54(5):805-10. PubMed ID: 2226914
[TBL] [Abstract][Full Text] [Related]
3. Effects of a superactive luteinizing hormone-releasing factor agonist on gonadotropin and ovarian function during the menstrual cycle.
Sheehan KL; Casper RF; Yen SS
Am J Obstet Gynecol; 1979 Nov; 135(6):759-63. PubMed ID: 386801
[TBL] [Abstract][Full Text] [Related]
4. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
[TBL] [Abstract][Full Text] [Related]
5. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
6. Chorionic gonadotropin prevents LRF-agonist-induced luteolysis in the human.
Casper RF; Sheehan KL; Yen SS
Contraception; 1980 May; 21(5):471-8. PubMed ID: 7000435
[TBL] [Abstract][Full Text] [Related]
7. Luteolytic effect of D-Trp6-luteinizing hormone-releasing hormone in the rhesus monkey (Macaca mulatta).
Asch RH; Siler-Khodr TM; Smith CG; Schally AV
J Clin Endocrinol Metab; 1981 Mar; 52(3):565-71. PubMed ID: 6450776
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of pituitary and corpus luteum responses to single intranasal administration of (D-ser[TBU]6-des-gly-NH2(10)) luteinizing hormone-releasing hormone ethylamide (Buserelin) in normal women.
Lemay A; Faure N; Labrie F
Fertil Steril; 1982 Feb; 37(2):193-200. PubMed ID: 6800846
[TBL] [Abstract][Full Text] [Related]
9. Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control.
Sheehan KL; Casper RF; Yen SS
Science; 1982 Jan; 215(4529):170-2. PubMed ID: 6797068
[TBL] [Abstract][Full Text] [Related]
10. Effects of a luteinizing hormone-releasing hormone agonist on luteal function in women.
Bergquist C; Nillius SJ; Wide L
Contraception; 1980 Sep; 22(3):287-93. PubMed ID: 7002443
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous pulsatile release of prolactin and luteinizing hormone induced by luteinizing hormone-releasing factor agonist.
Casper RF; Yen SS
J Clin Endocrinol Metab; 1981 May; 52(5):934-6. PubMed ID: 7014588
[TBL] [Abstract][Full Text] [Related]
12. Early follicular phase luteinizing hormone-releasing hormone agonist administration - effects on follicular maturation and corpus luteum function in women.
Skarin G; Nillius SJ; Wide L
Contraception; 1982 Jan; 25(1):31-9. PubMed ID: 6800690
[TBL] [Abstract][Full Text] [Related]
13. Action of luteinizing hormone-releasing factor (lrf) in the initiation of lordosis behavior in the estrone-primed ovariectomized female rat.
Moss RL; McCann SM
Neuroendocrinology; 1975; 17(4):309-18. PubMed ID: 806824
[TBL] [Abstract][Full Text] [Related]
14. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
15. Luteolysis induced by a luteinizing hormone-releasing hormone agonist is prevented by human chorionic gonadotropin.
Bergquist C; Nillius SJ; Wide L
Contraception; 1980 Oct; 22(4):341-7. PubMed ID: 7004772
[TBL] [Abstract][Full Text] [Related]
16. Luteolytic activity of LHRH and [D-Ser(TBU)6, des-Gly-NH2(10)]LHRH ethylamide: a new and physiological approach to contraception in women.
Lemay A; Labrie F; Raynaud JP
Int J Fertil; 1980; 25(3):203-12. PubMed ID: 6108931
[TBL] [Abstract][Full Text] [Related]
17. The induction of premature luteolysis in normal women--follicular phase luteinizing hormone secretion and corpus luteum function in the subsequent cycle.
Soules MR; Bremner WJ; Dahl KD; Rivier JE; Vale WW; Clifton DK
Am J Obstet Gynecol; 1991 Apr; 164(4):989-94; discussion 994-6. PubMed ID: 2014851
[TBL] [Abstract][Full Text] [Related]
18. Effect of postovulatory treatment with a luteinizing hormone-releasing hormone analog on the plasma level of progesterone in women.
Koyama T; Ohkura T; Kumasaka T; Saito M
Fertil Steril; 1978 Nov; 30(5):549-52. PubMed ID: 363461
[TBL] [Abstract][Full Text] [Related]
19. Induction of luteolysis in the human with a long-acting analog of luteinizing hormone-releasing factor.
Casper RF; Yen SS
Science; 1979 Jul; 205(4404):408-10. PubMed ID: 377491
[TBL] [Abstract][Full Text] [Related]
20. [Effects of an analog of LRH on luteal function in normal women; report of 18 cases].
Zhang L
Zhonghua Fu Chan Ke Za Zhi; 1986 Mar; 21(2):100-3, 126. PubMed ID: 3527596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
